Browse by "Nefroloxía"

Analysis of the incidence of resistance to erythropoiesis agents in patients undergoing peritoneal dialysis

2013- Lamas Díaz, María Jesús; Fernández Ferreiro, Anxo; Cabana Carcasi, Mara Lisbet; Echarri Arrieta, Eduardo; Alonso Valente, Rafael; [et al.]

Anemia and vitamin D Deficit in chronic kidney disease stages 2-5ND: A new vitamin D pathogenic role?

2011- Cigarrán Guldris, Secundino; Pousa Ortega, Montserrat

Anemia Control in Renal Transplant Recipients Receiving Continuous Erythropoietin Receptor Activator (C.E.R.A.) Treatment: The AnemiaTrans Study

2012- Romero Burgos, Rafael

Aplicaciones futuras de la bioimpedancia vectorial (BIVA) en nefrología

2011- Cigarrán Guldris, Secundino

Asleep, but not clinic or awake blood pressure mean, is an independent predictor of cardiovascular events: The Hygia Project

2014- Otero González, Alfonso; Dominguez Sardina, Manuel; Crespo Sabarís, Juan José; Rios Rey, Teresa

Asleep, but not daytime clinic or awake mean, blood pressure is an independent predictor of cardiovascular events in patients with diabetes: The hygia project

2015- Otero González, Alfonso; Castiñeira Pérez, Carmen

Asleep, but not daytime clinic or awake mean, blood pressure is an independent predictor of cardiovascular events in patients with diabetes: The Hygia project

2015- Otero González, Alfonso; Castiñeira Pérez, Carmen

Asleep, but not daytime clinic or awake mean, blood pressure is an independent predictor of cardiovascular events in patients with diabetes: The Hygia Project.

2015- Otero González, Alfonso; Castiñeira Pérez, Carmen

Assessment of health-related quality of life: the cinderella of peritoneal dialysis?

2011- Moreiras Plaza, María Mercedes; Blanco García, Raquel; Cossio Aranibar, Cynthia Raquel; Rodríguez Goyanes, María Gloria

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

2013- Cigarrán Guldris, Secundino

BLUNTED SLEEP-TIME BLOOD PRESSURE (BP) DECLINE INCREASES CARDIOVASCULAR RISK INDEPENDENT OF BP LEVEL

2014- Otero González, Alfonso; Moya Álvarez, Ana; Sineiro Galiñanes, Elvira; Crespo Sabarís, Juan José; Pousa Estevez, Lorenzo; [et al.]

Can we reduce the incidence of peritoneal catheter tunnel and exit site infections in peritoneal dialysis? Analysis of risk factors in a low incidence setting

2013- Pérez Fontán, Miguel; Rodríguez-Carmona de la Torre, Ana

Carotid atherosclerosis and body composition assessment by bioelectrical vectorial impedance in chronic kidney disease patients stage 2-5ND

2011- Cigarrán Guldris, Secundino; Pousa Ortega, Montserrat; Méndez Pérez, María Jesús; Porteiro Sanchez, Montserrat

Cavitaciones pulmonares múltiples

2011- Nuñez Viejo, Miguel Angel; Borrajo Prol, María Paz

Changes in peritoneal membrane permeability and proteinuria in patients on peritoneal dialysis after treatment with paricalcitol - a preliminary study.

2012- Cigarrán Guldris, Secundino

Cinacalcet en el manejo del hiperparatiroidismo secundario normocalcémico tras el trasplante renal: Estudio multicéntrico de un año de seguimiento

2014- Romero Burgos, Rafael

Cinacalcet for hypercalcaemic secondary hyperparathyroidism after renal transplantation: a multicentre, retrospective, 3-year study

2014- Romero Burgos, Rafael

CINACALCET FOR NORMO- AND HYPERCALCEMIC SECONDARY HYPERPARATHYROIDISM (SHPT) AFTER RENAL TRANSPLANT

2013- Romero Burgos, Rafael

Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

2015- Cigarrán Guldris, Secundino; Pérez Fontán, Miguel; Calviño Varela, Jesús; Novoa Fernández, Enrique; Lopez Prieto, Saray [et al.]

Clinical characteristics and long-term outcomes of patients undergoing combined heart-kidney transplantation: a single-center experience

2015- Barge Caballero, Eduardo; Crespo Leiro, Marisa; Fernandez Arias, Laura; López Sainz, Angela; Paniagua Martín, María Jesús; [et al.]

RUNA digital repository

Browse by "Nefroloxía"

Analysis of the incidence of resistance to erythropoiesis agents in patients undergoing peritoneal dialysis ﻿

Anemia and vitamin D Deficit in chronic kidney disease stages 2-5ND: A new vitamin D pathogenic role? ﻿

Anemia Control in Renal Transplant Recipients Receiving Continuous Erythropoietin Receptor Activator (C.E.R.A.) Treatment: The AnemiaTrans Study ﻿

Aplicaciones futuras de la bioimpedancia vectorial (BIVA) en nefrología ﻿

Asleep, but not clinic or awake blood pressure mean, is an independent predictor of cardiovascular events: The Hygia Project ﻿

Asleep, but not daytime clinic or awake mean, blood pressure is an independent predictor of cardiovascular events in patients with diabetes: The hygia project ﻿

Asleep, but not daytime clinic or awake mean, blood pressure is an independent predictor of cardiovascular events in patients with diabetes: The Hygia project ﻿

Asleep, but not daytime clinic or awake mean, blood pressure is an independent predictor of cardiovascular events in patients with diabetes: The Hygia Project. ﻿

Assessment of health-related quality of life: the cinderella of peritoneal dialysis? ﻿

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease ﻿

BLUNTED SLEEP-TIME BLOOD PRESSURE (BP) DECLINE INCREASES CARDIOVASCULAR RISK INDEPENDENT OF BP LEVEL ﻿

Can we reduce the incidence of peritoneal catheter tunnel and exit site infections in peritoneal dialysis? Analysis of risk factors in a low incidence setting ﻿

Carotid atherosclerosis and body composition assessment by bioelectrical vectorial impedance in chronic kidney disease patients stage 2-5ND ﻿

Cavitaciones pulmonares múltiples ﻿

Changes in peritoneal membrane permeability and proteinuria in patients on peritoneal dialysis after treatment with paricalcitol - a preliminary study. ﻿

Cinacalcet en el manejo del hiperparatiroidismo secundario normocalcémico tras el trasplante renal: Estudio multicéntrico de un año de seguimiento ﻿

Cinacalcet for hypercalcaemic secondary hyperparathyroidism after renal transplantation: a multicentre, retrospective, 3-year study ﻿

CINACALCET FOR NORMO- AND HYPERCALCEMIC SECONDARY HYPERPARATHYROIDISM (SHPT) AFTER RENAL TRANSPLANT ﻿

Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease ﻿

Clinical characteristics and long-term outcomes of patients undergoing combined heart-kidney transplantation: a single-center experience ﻿

Analysis of the incidence of resistance to erythropoiesis agents in patients undergoing peritoneal dialysis

Anemia and vitamin D Deficit in chronic kidney disease stages 2-5ND: A new vitamin D pathogenic role?

Anemia Control in Renal Transplant Recipients Receiving Continuous Erythropoietin Receptor Activator (C.E.R.A.) Treatment: The AnemiaTrans Study

Aplicaciones futuras de la bioimpedancia vectorial (BIVA) en nefrología

Asleep, but not clinic or awake blood pressure mean, is an independent predictor of cardiovascular events: The Hygia Project

Asleep, but not daytime clinic or awake mean, blood pressure is an independent predictor of cardiovascular events in patients with diabetes: The hygia project

Asleep, but not daytime clinic or awake mean, blood pressure is an independent predictor of cardiovascular events in patients with diabetes: The Hygia project

Asleep, but not daytime clinic or awake mean, blood pressure is an independent predictor of cardiovascular events in patients with diabetes: The Hygia Project.

Assessment of health-related quality of life: the cinderella of peritoneal dialysis?

Bardoxolone methyl in type 2 diabetes and stage 4 chronic kidney disease

BLUNTED SLEEP-TIME BLOOD PRESSURE (BP) DECLINE INCREASES CARDIOVASCULAR RISK INDEPENDENT OF BP LEVEL

Can we reduce the incidence of peritoneal catheter tunnel and exit site infections in peritoneal dialysis? Analysis of risk factors in a low incidence setting

Carotid atherosclerosis and body composition assessment by bioelectrical vectorial impedance in chronic kidney disease patients stage 2-5ND

Cavitaciones pulmonares múltiples

Changes in peritoneal membrane permeability and proteinuria in patients on peritoneal dialysis after treatment with paricalcitol - a preliminary study.

Cinacalcet en el manejo del hiperparatiroidismo secundario normocalcémico tras el trasplante renal: Estudio multicéntrico de un año de seguimiento

Cinacalcet for hypercalcaemic secondary hyperparathyroidism after renal transplantation: a multicentre, retrospective, 3-year study

CINACALCET FOR NORMO- AND HYPERCALCEMIC SECONDARY HYPERPARATHYROIDISM (SHPT) AFTER RENAL TRANSPLANT

Circulating angiotensin-converting enzyme 2 activity in patients with chronic kidney disease without previous history of cardiovascular disease

Clinical characteristics and long-term outcomes of patients undergoing combined heart-kidney transplantation: a single-center experience